James E. Montie
#120,056
Most Influential Person Now
James E. Montie's AcademicInfluence.com Rankings
James E. Montiephilosophy Degrees
Philosophy
#5406
World Rank
#8189
Historical Rank
Logic
#2690
World Rank
#3719
Historical Rank
James E. Montiebiology Degrees
Biology
#7219
World Rank
#10107
Historical Rank
Molecular Biology
#810
World Rank
#830
Historical Rank
Download Badge
Philosophy Biology
Why Is James E. Montie Influential?
(Suggest an Edit or Addition)James E. Montie's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. (2006) (2694)
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer (2005) (1539)
- Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. (2000) (1116)
- Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer (2007) (854)
- A common variant associated with prostate cancer in European and African populations (2006) (630)
- Autoantibody signatures in prostate cancer. (2005) (606)
- Germline mutations in HOXB13 and prostate-cancer risk. (2012) (555)
- A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. (1991) (541)
- Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. (2002) (456)
- Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. (2005) (388)
- JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence (2004) (353)
- Bladder Cancer in 2010: How Far have We Come? (2010) (327)
- Randomized clinical trial of a family intervention for prostate cancer patients and their spouses (2007) (301)
- Urinary tract abnormalities: initial experience with multi-detector row CT urography. (2002) (300)
- Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. (2008) (283)
- Bladder cancer. Clinical practice guidelines in oncology. (2005) (278)
- Prospective assessment of patient reported urinary continence after radical prostatectomy. (2000) (267)
- The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. (1977) (256)
- Identifying risk factors for potentially avoidable complications following radical cystectomy. (2005) (256)
- Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. (1989) (242)
- Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. (2006) (237)
- Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association. (1999) (229)
- Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. (2007) (220)
- Living with prostate cancer: patients' and spouses' psychosocial status and quality of life. (2007) (219)
- Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer. (2015) (214)
- Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. (2002) (208)
- Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. (1990) (205)
- Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer. (1999) (204)
- Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer (1989) (204)
- Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. (2003) (199)
- Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. (1997) (195)
- Prostate carcinoma presentation, diagnosis, and staging (2003) (183)
- Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. (2000) (179)
- Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. (2006) (179)
- MDCT urography of upper tract urothelial neoplasms. (2005) (174)
- Measuring health‐related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI) (2007) (174)
- Staging of prostate cancer (1994) (170)
- Impact of body mass index on radical cystectomy. (2004) (158)
- Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. (2004) (156)
- Radical cystectomy without radiation therapy for carcinoma of the bladder. (1984) (155)
- Delays in diagnosis and bladder cancer mortality (2010) (141)
- Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital. (2013) (140)
- Integrative analysis of genomic aberrations associated with prostate cancer progression. (2007) (139)
- The impact of co-morbid disease on cancer control and survival following radical cystectomy. (2003) (135)
- Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. (2000) (128)
- Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer. (2010) (126)
- The Cleveland Clinic experience with adrenal cortical carcinoma. (1989) (126)
- Bladder tumor detection at virtual cystoscopy. (2001) (125)
- Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer. (1990) (121)
- Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. (2005) (121)
- Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. (1995) (119)
- Acquired rectourethral fistula: methods of repair. (1995) (117)
- Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. (1989) (116)
- CONSTRUCTION OF MALE GENITALIA IN THE TRANSSEXUAL, USING A TUBED GROIN FLAP FOR THE PENIS AND A HYDRAULIC INFLATION DEVICE (1978) (116)
- Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy. (2003) (114)
- Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. (2003) (113)
- Salvage surgery for radiation failure in prostate cancer (1993) (111)
- Functional anatomy of the prostate: implications for treatment planning. (2005) (110)
- The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. (2008) (109)
- Nephron sparing surgery for suspected malignancy: open surgery compared to laparoscopy with selective use of hand assistance. (2000) (105)
- Prostate Needle Biopsy Reporting: How Are the Surgical Members of the Society of Urologic Oncology Using Pathology Reports to Guide Treatment of Prostate Cancer Patients? (2004) (103)
- Renal cell carcinoma with inferior vena cava tumor thrombi. (1991) (102)
- Genome‐wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1 (2003) (101)
- Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. (1994) (98)
- Measuring to Improve: Peer and Crowd-sourced Assessments of Technical Skill with Robot-assisted Radical Prostatectomy. (2016) (97)
- Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. (2003) (97)
- Cancer survivorship: challenges and changing paradigms. (2008) (97)
- Magnetic resonance imaging for assessment of vena caval tumor thrombi: a comparative study with venacavography and computerized tomography scanning. (1990) (97)
- Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. (2006) (94)
- Features of the metabolic syndrome and prostate cancer in African‐American men (2007) (94)
- Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. (2005) (94)
- Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. (2006) (91)
- The regionalization of radical cystectomy to specific medical centers. (2005) (88)
- ETS rearrangements and prostate cancer initiation (2009) (87)
- Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men. (2001) (84)
- Provider treatment intensity and outcomes for patients with early-stage bladder cancer. (2009) (83)
- Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial. (2004) (83)
- Identification of transitional cell carcinoma of the prostate in bladder cancer patients: a prospective study. (1989) (81)
- The effects of adjusting for case mix on mortality and length of stay following radical cystectomy. (2006) (80)
- Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men. (2003) (79)
- Comparison of patients' and physicians' rating of urinary incontinence following radical prostatectomy. (2000) (78)
- A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy. (2015) (78)
- Prospective comparison between hand-assisted laparoscopic and open surgical nephroureterectomy for urothelial cell carcinoma. (2001) (78)
- Exploring the role of the partner in couples’ sexual recovery after surgery for prostate cancer (2014) (76)
- Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate. (1985) (74)
- Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer (2004) (73)
- Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men. (2002) (73)
- Patient preoperative expectations of urinary, bowel, hormonal and sexual functioning do not match actual outcomes 1 year after radical prostatectomy. (2011) (72)
- What couples say about their recovery of sexual intimacy after prostatectomy: toward the development of a conceptual model of couples' sexual recovery after surgery for prostate cancer. (2015) (72)
- Urologic Oncology: Seminars and Original Investigations - Introduction (2003) (71)
- Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. (2008) (69)
- Postoperative ileus after abdominal surgery. (2002) (68)
- Long-term results following partial nephrectomy for localized renal adenocarcinoma. (1984) (68)
- Lymphadenectomy in renal adenocarcinoma. (1982) (67)
- Ureteropyeloscopy in the evaluation of upper tract filling defects. (1986) (67)
- Conservative surgery for transitional cell carcinoma of the renal pelvis. (1987) (66)
- Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men. (2008) (65)
- Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma. (2000) (65)
- Prostatic cryotherapy: ultrasonographic and pathologic correlation in the canine model. (1994) (64)
- Experience with extra-adrenal pheochromocytoma. (1989) (64)
- Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer. (2003) (64)
- Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial. (2009) (64)
- Relationship of serum sex‐steroid hormones and prostate volume in African American men (2002) (63)
- Utility of cytokeratin 20 and Ki‐67 as markers of urothelial dysplasia (2005) (62)
- Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: A retrospective cohort study (1997) (59)
- Prognostic indicators in renal adenocarcinoma. (1983) (59)
- Follow-up after partial or total nephrectomy for renal cell carcinoma. (1994) (59)
- Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder. (2008) (59)
- Against bladder sparing: surgery. (1999) (59)
- Combination radiation and chemotherapy for the treatment of squamous cell carcinoma of the male and female urethra. (1995) (58)
- Intraoperative nerve stimulation with measurement of urethral sphincter pressure changes during radical retropubic prostatectomy: a feasibility study. (2003) (58)
- Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer. (2006) (58)
- Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer. (2011) (57)
- Radical cystectomy for carcinoma of the bladder in the elderly patient. (1987) (57)
- Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer. (2000) (56)
- Intravesical bacille calmette-guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. (2005) (56)
- Renal oncocytoma: a diagnostic and therapeutic dilemma. (1984) (56)
- Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. (2013) (56)
- Prognosis of Muscle-Invasive Bladder Cancer: Difference Between Primary and Progressive Tumours and Implications for Therapy (2005) (55)
- Tumor‐Infiltrating Lymphocytes in Patients with Renal‐Cell Carcinoma (1988) (55)
- Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder. (2005) (54)
- Retroperitoneal neural sheath tumors: Cleveland Clinic experience. (1989) (53)
- Resection of large inferior vena caval thrombi from renal cell carcinoma with the use of circulatory arrest. (1988) (53)
- Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy. (2002) (53)
- The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup. (2006) (52)
- NCCN Urothelial Cancer Practice Guidelines (1998) (52)
- Manifestations of renal cell carcinom (1976) (52)
- Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively? (2001) (51)
- Hautmann and Studer orthotopic neobladders: a contemporary experience. (2003) (51)
- Risk factors and quality of life for post-prostatectomy vesicourethral anastomotic stenoses. (2012) (51)
- Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative. (2014) (51)
- Establishment of a urological surgery quality collaborative. (2010) (50)
- Short-term health outcome differences between robotic and conventional radical prostatectomy. (2007) (50)
- The natural history of lower urinary tract symptoms in black American men: relationships with aging, prostate size, flow rate and bothersomeness. (2001) (49)
- Risk factors for adverse outcomes after transurethral resection of bladder tumors (2006) (49)
- Surgical treatment of localized renal cell carcinoma in von Hippel-Lindau's disease. (1988) (48)
- Management of the urethra in men undergoing radical cystectomy for bladder cancer. (1984) (48)
- Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy. (2003) (48)
- Hospital lymph node counts and survival after radical cystectomy (2008) (47)
- Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion. (2007) (47)
- Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features. (2000) (47)
- Trends in the utilization of androgen‐deprivation therapy for patients with prostate carcinoma suggest an effect on mortality (2001) (47)
- Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area: 1973‐1994 (1996) (47)
- Use of advanced treatment technologies among men at low risk of dying from prostate cancer. (2013) (46)
- Understanding the use of immediate intravesical chemotherapy for patients with bladder cancer. (2012) (45)
- Assessment of early continence recovery after radical prostatectomy: patient reported symptoms and impairment. (2001) (45)
- Cost‐effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer (2018) (44)
- Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease. (1999) (44)
- Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle‐invasive bladder cancer (2012) (44)
- Appropriateness Criteria for Active Surveillance of Prostate Cancer (2017) (44)
- In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma. (1976) (43)
- Impact of surgical volume on mortality and length of stay after nephrectomy. (2004) (43)
- The discovery and application of gene fusions in prostate cancer (2008) (42)
- The effects of stage divergence on survival after radical cystectomy for urothelial cancer. (2005) (42)
- Toward better use of bone scans among men with early-stage prostate cancer. (2014) (42)
- Bilateral emphysematous pyelonephritis. (1985) (42)
- Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancer. (2013) (42)
- Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens. (2000) (41)
- Free flap phalloplasty. (1982) (40)
- Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors. (2000) (40)
- Comparing performance of Morbidity and Mortality Conference and National Surgical Quality Improvement Program for detection of complications after urologic surgery. (2006) (40)
- Jejunal conduit urinary diversion. (1986) (39)
- Development and validation of the convalescence and recovery evaluation (CARE) for measuring quality of life after surgery (2008) (39)
- Orthotopic bladder substitution in women: nontraditional applications. (2004) (39)
- Immunotherapy of disseminated renal cell carcinoma with transfer factor. (1977) (38)
- Nephron-sparing surgery for renal cell carcinoma with venous involvement. (1990) (38)
- A Pilot Study of Potential Pre-Operative Barriers to Couples’ Sexual Recovery After Radical Prostatectomy for Prostate Cancer (2015) (38)
- Early onset prostate cancer: predictors of clinical grade. (2002) (37)
- Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: multivariate nomogram to assist patient counseling. (2004) (36)
- Frequency of residual neoplasm in the prostate following three‐dimensional conformal radiotherapy (1993) (36)
- Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer. (2008) (35)
- Incontinent or continent urinary diversion: how to make the right choice (2010) (35)
- The risk of radical cystectomy. (1989) (35)
- Staging of prostate cancer. Current TNM classification and future prospects for prognostic factors (1995) (35)
- Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy. (2004) (34)
- Collagen injection for the treatment of incontinence after cystectomy and orthotopic neobladder reconstruction in women. (2000) (34)
- Current prognostic factors for prostate carcinoma (1996) (34)
- Assessment of long‐term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy (2015) (34)
- Retroperitoneal malignancies several years after initial treatment of germ cell cancer of the testis (1984) (34)
- The role of serum prostatic acid phosphatase as a tumor marker in men with advanced adenocarcinoma of the prostate. (1984) (34)
- Use of quality indicators to evaluate the care of patients with localized prostate carcinoma (2003) (34)
- Pelvic recurrences post cystectomy: current treatment strategies. (2001) (34)
- Clinical and in vitro magnetic resonance imaging of prostatic carcinoma. (1984) (34)
- Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic (2015) (34)
- Orthotopic urinary diversion is a viable option in patients undergoing salvage cystoprostatectomy for recurrent prostate cancer after definitive radiation therapy. (1997) (33)
- Ureterocalicostomy for reconstruction of complicated pelviureteric junction obstruction. (1990) (33)
- Intra-arterial chemotherapy as an adjuvant to surgery in transitional cell carcinoma of the bladder. (1986) (33)
- Recent trends in incidence and treatment of prostate cancer among elderly men. (1995) (33)
- Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study. (1989) (32)
- Mechanisms of incontinence and retention after orthotopic neobladder diversion. (1998) (32)
- Intravasal stents for vasovasostomy in canine subjects. (1973) (31)
- NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. (1998) (30)
- A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer (2017) (30)
- Obesity adversely affects health related quality of life before and after radical retropubic prostatectomy. (2006) (30)
- A one-day couple group intervention to enhance sexual recovery for surgically treated men with prostate cancer and their partners: a pilot study. (2013) (30)
- Bladder cancer. Clinical guidelines in oncology. (2006) (30)
- Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial. (2015) (30)
- Clinical predictors and recommendations for staging computed tomography scan among men with prostate cancer. (2014) (29)
- Counseling the patient with localized prostate cancer. (1994) (29)
- Quality of Care in Urology and the Michigan Urological Surgery Improvement Collaborative (2014) (29)
- Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy. (2007) (29)
- Resection of inferior vena cava tumor thrombi from renal cell carcinoma. (1991) (29)
- Defining the ideal tumor marker for prostate cancer. (1997) (28)
- A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the bladder. (2013) (28)
- Retrograde ureteroscopy in patients with orthotopic ileal neobladder urinary diversion. (2003) (28)
- Measuring the quality of care for localized prostate cancer. (2005) (28)
- Preparing Patients and Partners for Recovery From the Side Effects of Prostate Cancer Surgery: A Group Approach. (2016) (28)
- Comparative effectiveness of external-beam radiation approaches for prostate cancer. (2014) (27)
- Clinical staging of prostate cancer: Reproducibility and clarification of issues (2001) (27)
- Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy (2016) (27)
- Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. (2004) (27)
- Follow-up after radical prostatectomy or radiation therapy for prostate cancer. (1994) (26)
- A Roadmap for Improving the Management of Favorable Risk Prostate Cancer. (2017) (26)
- Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy (2014) (26)
- Male infertility: an optimistic report. (1973) (26)
- Sexual Health Concerns Among Cancer Survivors: Testing a Novel Information-Need Measure Among Breast and Prostate Cancer Patients (2016) (26)
- Vasovasostomy: past, present and future. (1974) (26)
- MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancer. (2015) (25)
- Inferior venacavography in the preoperative assessment of renal adenocarcinoma. (1982) (25)
- Radical cystectomy for bladder cancer after definitive prostate cancer treatment. (2003) (25)
- Understanding bladder cancer death (2009) (25)
- Value of preoperative PSA in predicting pathologic stage of patients undergoing salvage prostatectomy. (1994) (25)
- Analysis of three‐dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer. (2001) (25)
- Cutaneous ureterostomy as palliative diversion in adults with malignancy. (1987) (25)
- Continent ileal urinary reservoir (Kock pouch). (1986) (25)
- Improvement in clinical TNM staging documentation within a prostate cancer quality improvement collaborative. (2014) (25)
- Establishment of a Web-based System for Collection of Patient-reported Outcomes After Radical Prostatectomy in a Statewide Quality Improvement Collaborative. (2017) (24)
- Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance (2010) (24)
- The state of prostate cancer screening in the United States. (1993) (24)
- Evaluating the Accreditation Council on Graduate Medical Education core clinical competencies: techniques and feasibility in a urology training program. (2003) (24)
- Orthotopic neobladder reconstruction: findings on excretory urography and CT. (1999) (24)
- Neoadjuvant intra-arterial chemotherapy in the treatment of advanced transitional cell carcinoma of the bladder: results and followup. (1989) (23)
- Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: a tool to facilitate treatment decisions. (2003) (23)
- Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance (2018) (23)
- The significance and management of transitional cell carcinoma of the prostate. (1990) (23)
- The surgical complications of renal transplantation. (1971) (23)
- Carcinoma of the prostate: treatment with pelvic lymphadenectomy and iodine-125 implants. (1979) (23)
- Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results. (2005) (22)
- Selection of the type of urinary diversion in conjunction with radical cystectomy. (1987) (22)
- A comparison of the W-stapled ileal reservoir with hand-sewn reservoirs for orthotopic bladder replacement. (1998) (22)
- A critical review of immunotherapy of disseminated renal adenocarcinoma (1982) (22)
- Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: the Flint Men's Health Study. (2004) (22)
- Regionalization of care: centralizing complex surgical procedures (2005) (21)
- Follow-up after cystectomy for carcinoma of the bladder. (1994) (21)
- Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program. (2004) (21)
- Radical cystectomy in the elderly: comparison of survival between younger and older patients. (2005) (20)
- Evaluation of point-of-care PRO assessment in clinic settings: integration, parallel-forms reliability, and patient acceptability of electronic QOL measures during clinic visits (2016) (20)
- Early urinary retention after catheter removal following radical prostatectomy predicts for future symptomatic urethral stricture formation. (2007) (20)
- Observations on the epidemiology and natural history of prostate cancer (1994) (20)
- Whitmoreisms: memorable quotes from Willet F. Whitmore, Jr, M.D. (2004) (20)
- Notable Outcomes and Trackable Events after Surgery: Evaluating an Uncomplicated Recovery after Radical Prostatectomy. (2016) (19)
- Transitional cell carcinoma in situ of the seminal vesicles: 8 cases with discussion of pathogenesis, and clinical and biological implications. (1997) (19)
- Massive bladder hemorrhage after cystoscopy in a patient with secondary systemic amyloidosis. (1973) (19)
- Certificate of need legislation and the dissemination of robotic surgery for prostate cancer. (2013) (19)
- Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries. (2011) (18)
- The role of magnetic resonance imaging in the staging of bladder carcinoma. (1988) (18)
- Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate Cancer. (2018) (18)
- Stomal complications of intestinal conduit urinary diversion. (1989) (18)
- Laparoscopic surgical technique for internal drainage of pelvic lymphocele. (1992) (18)
- Risk of Becoming Lost to Follow-up During Active Surveillance for Prostate Cancer. (2018) (18)
- Clinical Management of Premalignant Lesions of the Prostate (2000) (18)
- Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy. (2019) (18)
- Standardization of radical cystectomy: Time to count and be counted (2004) (17)
- Preoperative and intraoperative risk factors associated with 30-day morbidity following urological surgery: the National Surgical Quality Improvement Program. (2006) (17)
- Reducing Bias in the Assessment of Treatment Effectiveness: Androgen Deprivation Therapy for Prostate Cancer (2012) (16)
- Initial therapy with radical prostatectomy for high risk localized prostate cancer. (2006) (16)
- Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer. (2014) (16)
- AUA Quality Improvement Summit 2014: Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy (2015) (16)
- Artificial neural networks for prostate carcinoma risk assessment (2000) (16)
- Adoption of new technology and healthcare quality: surgical margins after robotic prostatectomy. (2007) (16)
- Potential Implications of Shortening Length of Stay Following Radical Cystectomy in a Pre-ERAS Population. (2017) (15)
- Patient Psoas Muscle Mass as a Predictor of Complications and Survival After Radical Cystectomy (2015) (15)
- Variation in prostate cancer detection rates in a statewide quality improvement collaborative. (2014) (15)
- The role of imaging in the surveillance of urologic malignancies. (2006) (15)
- A comparison of adjustments to urinary diversions: a pilot study. (1995) (15)
- Are we targeting the right outcome for sexual health after prostate cancer treatment? (2015) (15)
- MAXIMUM TUMOR DIMENSION PROVIDES A CLINICALLY USEFUL AND INDEPENDENTLY SIGNIFICANT MEASURE FOR PREDICTING PSA-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY (1999) (15)
- Urethral cancer. (2012) (15)
- Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer. (2015) (14)
- Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence. (2005) (14)
- Urology residency and research: round table discussion and plea for innovation. (2008) (14)
- Carcinoma in situ of the testis and bilateral carcinoma. (1993) (14)
- Counseling patients about sexual health when considering post-prostatectomy radiation treatment (2009) (14)
- Unresectable carcinoma of the bladder (1983) (14)
- Salvage surgery for renal cell carcinoma. (1989) (14)
- Ileal conduit diversion after radical cystectomy: pro. (1997) (14)
- A unifying model to explain the increased incidence and higher mortality of prostate cancer in black men. (1999) (13)
- Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance. (2018) (13)
- Histologic Grading of Noninvasive Papillary Urothelial Tumors. Validation of the 1998 WHO/ISUP System by Immunophenotyping and Follow-Up. (2005) (13)
- Analysis of three-dimensional ultrasound Doppler for the detection of prostate cancer. (2001) (13)
- Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomy. (1998) (13)
- W-stapled ileal neo-bladder formed entirely with absorbable staples. (1994) (13)
- Association between family history of prostate and breast cancer among African-American men with prostate cancer. (2006) (13)
- Bladder cancer. (2009) (12)
- Perioperative complications of adrenal surgery. (1989) (12)
- 192 Wisdom of the crowds: Use of crowdsourcing to assess surgical skill of robot-assisted radical prostatectomy in a statewide surgical collaborative (2015) (12)
- Eleventh Prouts Neck Meeting on Prostate Cancer: emerging strategies in prostate cancer therapy. (2007) (12)
- Workgroup 3: Current prognostic factors and their relevance to staging (1996) (12)
- A phase II trial of neoadjuvant ABI-007, carboplatin, and gemcitabine (ACG) in patients with locally advanced carcinoma of the bladder. (2011) (12)
- 1417 EFFICIENT DELIVERY OF RADICAL CYSTECTOMY AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER: A MULTIDISCIPLINARY APPROACH (2011) (12)
- The incidental renal mass. Management alternatives. (1991) (11)
- Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer. (2018) (11)
- Artificial neural networks for prostate carcinoma risk assessment: An overview. (2000) (11)
- Radical cystectomy and surgical quality of care. (2005) (11)
- Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups (2019) (11)
- Concurrent assessment of obstructive/irritative urinary symptoms and incontinence after radical prostatectomy. (2002) (10)
- 1162: Neuromodulation to Preserve Erectile Function After Radical Prostatectomy: Results from the GPI1485 Neuroimmunophilin Ligand Clinical Trial (2007) (10)
- INSPstI polymorphism and prostate cancer in African‐American men (2005) (10)
- Understanding the Use of Prostate Biopsy Among Men with Limited Life Expectancy in a Statewide Quality Improvement Collaborative. (2016) (10)
- Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. 1989. (2002) (10)
- Comparison of modified Taguchi and Bricker ureteral reimplantation techniques after radical cystectomy. (2004) (10)
- Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy From a Statewide Improvement Collaborative. (2021) (10)
- Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies (2018) (10)
- Artificial neural networks for prostate carcinoma risk assessment (2001) (10)
- THE USE OF % FREE PSA (%fPSA) TO PREDICT PROSTATE CANCER PROBABILITIES: AN ELEVEN CENTER PROSPECTIVE STUDY USING AN AUTOMATED IMMUNOASSAY SYSTEM IN A POPULATION WITH NON-SUSPICIOUS DRE (1999) (10)
- Editorial: Prognostic Factors for Renal Cell Carcinoma (1994) (9)
- Interobserver consistency of digital rectal examination in clinical staging of localized prostatic carcinoma. (1995) (9)
- Quality of Care for Renal Masses: The Michigan Urological Surgery Improvement Collaborative—Kidney Mass: Identifying & Defining Necessary Evaluation & Therapy (MUSIC-KIDNEY) (2020) (9)
- Certificate of need regulations and the diffusion of intensity-modulated radiotherapy. (2012) (9)
- Two-Stage Biomarker Protocols for Improving the Precision of Early Detection of Prostate Cancer (2017) (9)
- Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy? (2005) (9)
- Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer. (2012) (9)
- Formation of an orthotopic neobladder following radical cystectomy:: Historical perspective, patient selection, and contemporary outcomes (2002) (9)
- Conflict of interest in urology. (2012) (9)
- Validity of the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction Measures in Men Following Radical Prostatectomy. (2019) (8)
- Understanding the Performance of Active Surveillance Selection Criteria in Diverse Urology Practices. (2015) (8)
- What are the risks of cystectomy and the advances in perioperative care? (1995) (8)
- Isolated recurrent renal cell carcinoma metastatic to the bladder. (2002) (8)
- Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study. (2005) (8)
- Functional equivalence of end and loop ileal conduit stomas. (1992) (8)
- Bladder injuries. (1977) (8)
- TECHNICAL SKILL ASSESSMENT OF SURGEONS PERFORMING ROBOT‐ASSISTED RADICAL PROSTATECTOMY: RELATIONSHIP BETWEEN CROWDSOURCED REVIEW AND PATIENT OUTCOMES: PNFBA‐02 (2017) (8)
- Counseling the patient with regional metastasis of prostate cancer (1993) (8)
- Role of percutaneous nephrostomy in patients with upper urinary tract transitional cell carcinoma. (1991) (8)
- Benign positive margins after radical prostatectomy means a poor prognosis--con. (2005) (7)
- Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. (2005) (7)
- Evaluation of a needle disinfectant technique to reduce infection‐related hospitalisation after transrectal prostate biopsy (2018) (7)
- Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience (2020) (7)
- Quality of care and performance-based reimbursement: the contemporary landscape and implications for urologists. (2006) (7)
- T1 bladder cancer: advocating early cystectomy to improve oncologic control. (2010) (7)
- 1992 staging system for prostate cancer. (1993) (7)
- Repeat Prostate Biopsy Practice Patterns in a Statewide Quality Improvement Collaborative (2017) (7)
- Anesthetic management for surgical removal of renal carcinoma with caval or atrial tumor thrombus using deep hypothermic circulatory arrest. (1989) (7)
- Follow-up after penectomy for penile cancer. (1994) (7)
- Follow-up after radical orchiectomy for testicular cancer. (1994) (7)
- 1234: Presence, Location and Significance of Prostate Cancer in Patients Undergoing Radical Cystoprostatectomy: Feasibility of Prostate Capsule Sparing Cystectomy (2006) (7)
- MAINTENANCE BCG IMMUNOTHERAPY: EVIDENCE OF ADDITIONAL PROTECTION AGAINST CANCER (1999) (7)
- Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer. (1990) (7)
- 552: Patient-Reported Outcomes after Retropubic, Laparoscopic, or Robot-Assisted Prostatectomy: Results from a Prospective, Multi-Center Study (2007) (6)
- Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance. (2020) (6)
- Early cystectomy for clinical stage T1 bladder cancer (2004) (6)
- 911: Lymphovascular Invasion is an Independent Predictor of Survival in CTl Bladder Cancer (2005) (6)
- Radical Cystectomy and Pelvic Lymphadenectomy in the Treatment of Infiltrative Bladder Cancer (2001) (6)
- Pathologic Evaluation of Radical Cystectomy Specimens. A Cooperative Group Report (2005) (6)
- Decreasing age at prostate cancer diagnosis over successive generations in prostate cancer families (2005) (6)
- Accuracy of preoperative studies in staging nonseminomatous germ cell testicular tumors. (1978) (6)
- The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder. A metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapy. (2005) (6)
- Prognostic factors for renal cell carcinoma. (1994) (6)
- Summary of complications of ureteroileal conduit with radical cystectomy: review of 336 cases (by Jerry W. Sullivan, MD, Harry Grabstald, MD, and Willet F. Whitmore, Jr). 1980. (1997) (6)
- Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR). (2018) (6)
- Digital subtraction angiography for evaluating patients with renal carcinoma. (1985) (6)
- MP50-06 MICROPAPILLARY DIFFERENTIATION VERSUS CONVENTIONAL UROTHELIAL CARCINOMA: EFFECTS OF NEOADJUVANT CHEMOTHERAPY AND CYSTECTOMY ON SURVIVAL (2014) (6)
- 137: Regionalization of Radical Cystectomy (2004) (6)
- Aggressive management of elderly patients with muscle-invasive bladder cancer (2006) (6)
- CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. (2005) (6)
- Southwest Oncology Group Comparison of Bacillus Calmette-Guerin and Doxorubricin in the Treatment and Prophylaxis of Superficial Bladder Cancer (1987) (6)
- VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasms (2004) (6)
- Use of Routine Home Health Care and Deviations From an Uncomplicated Recovery Pathway After Radical Prostatectomy. (2017) (6)
- Determining when to recommend continent urinary diversion. (2013) (6)
- Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group study. (1992) (6)
- Interpositional Nerve Grafting of the Prostatic Plexus after Radical Prostatectomy (2015) (5)
- VIDEO ANALYSIS OF SKILL AND TECHNIQUE (VAST): MACHINE LEARNING TO ASSESS SURGEONS PERFORMING ROBOTIC PROSTATECTOMY: PD46‐04 (2017) (5)
- The management of bladder outlet obstruction due to prostate cancer, untreated and after endocrine treatment (1992) (5)
- A glimpse at the future of some endocrine aspects of prostate cancer (1996) (5)
- Implementation of prostate cancer treatment decision aid in Michigan: a qualitative study (2020) (5)
- 1151: Perioperative Quality Care Indicators of Retropubic, Laparoscopic, and Robotic Prostatectomy: Results from a National, Multi-Center, Prospective Cohort (2006) (5)
- Identifying Better Practices for Early-stage Bladder Cancer (2011) (5)
- BLADDER NECK-SPARING TECHNIQUE ADVERSELY AFFECTS ANTI-TUMOR EFFICACY OF RADICAL PROSTATECTOMY IN PATHOLOGIC T3a PROSTATE CANCER (1999) (4)
- African-American men, high cholesterol & hs-CRP & alternative medicine use documented at a prostate cancer screening: A unique opportunity for a complete men's health intervention (2005) (4)
- 1086: Retrograde Ureteroscopy in Patients with Orthotopic Ileal Neobladder Urinary Diversion: An Update (2006) (4)
- Overtreatment and underutilization of watchful waiting in men with limited life expectancy: an analysis of the Michigan Urological Surgery Improvement Collaborative Registry. (2019) (4)
- 18: Measuring Quality-of-Life after Surgery: Development and Validation of the Convalescence and Recovery Evaluation (CARE) (2007) (4)
- MP44-11 PATIENT SELECTION AND OUTCOMES BETWEEN LOW AND HIGH VOLUME SURGEONS IN PERFORMANCE OF RADICAL PROSTATECTOMY IN THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE (MUSIC) (2019) (4)
- Quality of care in urology (2004) (4)
- Lymphadenectomy for renal cell carcinoma. (1989) (4)
- Experience with 45 Consecutive Patients with Neobladders Undergoing Retrograde Ureteroscopy for Upper Tract Abnormalities (2015) (4)
- 36: Measuring Health-Related Quality of Outcomes in Bladder Cancer Patients using the Newly Validated Bladder Cancer Index (BCI) (2006) (4)
- VALIDATION OF THE PARTIN TABLES FOR PREDICTING PATHOLOGIC STAGE OF CLINICALLY CONFINED PROSTATE CANCER (1999) (4)
- GENDER DIFFERENCES IN URINARY FUNCTION AFTER ORTHOTOPIC NEOBLADDER (1999) (4)
- SIGNIFICANCE OF GLEASON PATTERN 4 AS AN INDEPENDENT PROGNOSTIC INDICATOR OF POSTOPERATIVE PSA FAILURE IN PROSTATIC ADENOCARCINOMA (1999) (4)
- Delayed Urological Cancer Care during the COVID-19 Pandemic: Urologists' Experience. (2020) (4)
- The significance of cancer after renal transplantation. (1979) (4)
- Orthotopic Diversion in Men and Women (1997) (3)
- Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium. (2019) (3)
- Adult Preventive Health Care: Cancer Screening (2007) (3)
- Significance and treatment of positive margins or seminal vesicle invasion after radical prostatectomy. (1990) (3)
- Patient- and Surgeon-Level Variation in Patient-Reported Sexual Function Outcomes Following Radical Prostatectomy Over 2 Years: Results From a Statewide Surgical Improvement Collaborativep. (2021) (3)
- "Bench surgery" for renal cell carcinoma: a proper niche. (1992) (3)
- Orthotopic diversion in women. (1997) (3)
- Improving outcomes after radical cystectomy. (2008) (3)
- Neoadjuvant docetaxel and capecitabine in patients with high risk/locally advanced prostate cancer: Preliminary results of a phase II study (2005) (3)
- Neoadjuvant M-VAC with Intra-Arterial (I.A.) Cis-Platin in Locally Advanced Transitional Cell Carcinoma of the Bladder: Phase I/II Trial (1987) (3)
- RECOVERY AFTER ABDOMINAL AND PELVIC SURGERY (2008) (3)
- Intravesical therapy for bladder cancer: empiricism at the helm. (2001) (3)
- OUTCOMES FOR RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: WHAT REALLY MATTERS? (2007) (3)
- High-stage bladder cancer: bladder preservation or reconstruction? (1990) (3)
- Incidental carcinoma of the kidney: how to approach it (1993) (3)
- Patient preferences and treatment decisions for prostate cancer: Results from a statewide urological quality improvement collaborative. (2021) (3)
- Excessive antidiuretic hormone secretion after radical cystectomy. (1985) (3)
- Neoadjuvant paclitaxel (P), carboplatin (Ca) and gemcitabine (G) in patients with locally advanced transitional cell carcinoma (TCC) of the bladder: A final report. (2006) (3)
- Regular vs. selective use of closed suction drains following robot-assisted radical prostatectomy: results from a regional quality improvement collaborative (2019) (3)
- 35: Development and Validation of the Bladder Cancer Index (BCI): A Disease Specific Measure of Quality of life (2006) (3)
- Limitations of abdominopelvic CT and multiparametric MR imaging for detection of lymph node metastases prior to radical prostatectomy (2020) (3)
- 827: Salvage Therapy Adversely Effects Long-Term Hrqol among Localized Prostate Cancer Treatment Survivors (2005) (2)
- OR Practice-Data Analytics for Optimal Detection of Metastatic Prostate Cancer (2021) (2)
- Prospective randomized trial of gene expression classifier utility following radical prostatectomy (G-MINOR). (2021) (2)
- Guideline application and the real world. (2014) (2)
- Combination chemotherapy including VP-16 in poor prognosis germinal cell neoplasms (1982) (2)
- Detection of Occult Tumor Cells in Lymph Nodes From Bladder Cancer Patients by MUC7 Nested RT-PCR (2005) (2)
- PD43-12 EFFECT OF TREATMENT DELAY ON LONG-TERM OUTCOMES IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER. (2015) (2)
- Caveats for modeling disease free survival after radical prostatectomy (2000) (2)
- Partial nephrectomy for renal cell carcinoma. (1987) (2)
- Changing concepts in the management of testis cancer. (1984) (2)
- Factors Associated with Decision Aid Use in Localized Prostate Cancer (2021) (2)
- Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Reply. (2021) (2)
- Office management of urinary stomas. (1988) (2)
- SURGICAL SKILL AND PATIENT OUTCOMES AFTER ROBOT‐ASSISTED RADICAL PROSTATECTOMY: PD58‐06 (2017) (2)
- Morbidity of Inguinal Lymphadenectomy for Invasive Penile Carcinoma (2005) (2)
- Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative. (2020) (2)
- American Urological Association, American College of Emergency Physicians and American College of Radiology Quality Improvement Summit 2017: Challenges and Opportunities for Stewardship of Urological Imaging (2019) (2)
- Treatment of muscle-invasive bladder cancer: is cystectomy enough? (2007) (2)
- Atlas of Clinical Oncology: Prostate Cancer (2003) (2)
- Bladder, penis and urethral cancer, and basic principles of oncology. (2006) (2)
- Tomlins et al. reply (2009) (2)
- Recurrent gene fusions in prostate cancer: ETV1 class of fusions (2007) (2)
- 1520: Comparison of Lymphovascular Invasion in Turbt and Radical Cystectomy Specimens from Patients with Urothelial Carcinoma (2007) (2)
- The outlook for preserving continence and potency during radical prostatectomy. (1994) (2)
- Urologic oncology patient perspectives during COVID-19 treatment delays (2021) (2)
- Paclitaxel, carboplatin and gemcitabine (PCG) as neoadjuvant therapy in patients with locally advanced transitional cell carcinoma (TCC) of the bladder. (2004) (1)
- Collecting system invasion in renal cell carcinoma: Impact on prognosis and future staging strategies. Editorial comment (2003) (1)
- Prospective monitoring of imaging guideline adherence by physicians in a surgical collaborative: comparison of statistical process control methods for detecting outlying performance (2020) (1)
- Initial observations and problems with in vitro predictive assay in genitourinary malignancies. (1984) (1)
- In vitro activation of lymphocytes by interleukin 2 in patients with renal cell carcinoma. (1989) (1)
- Dynamic MRI of Bladder Cancer: Evaluation of Staging Accuracy (2005) (1)
- PD38-08 MULTI-INSTITUTIONAL PROSPECTIVE VALIDATION OF THE NOVEL MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE TRANSPERINEAL BIOPSY TEMPLATE (2020) (1)
- Assessing the impact of decision aid use on post prostatectomy patient reported outcomes. (2022) (1)
- MP15-03 APPROPRIATENESS CRITERIA FOR ACTIVE SURVEILLANCE FOR PROSTATE CANCER FROM THE MICHIGAN UROLOGIC SURGERY IMPROVEMENT COLLABORATIVE (2016) (1)
- SALVAGE RADICAL CYSTOPROSTATECTOMY AND ORTHOTOPIC URINARY DIVERSION FOLLOWING RADIATION FAILURE: EDITORIAL COMMENT (1998) (1)
- Profiling the evolution of human metastatic bladder cancer. (2005) (1)
- Bladder cancer: deciding on appropriate surgery. (1989) (1)
- Controversies in the early detection of prostate cancer. (1994) (1)
- Combination chemotherapy including VP-16 for poor prognosis germ cell neoplasms. (1988) (1)
- 1750 VARIANT HISTOLOGY IN BLADDER CANCER: SURVIVAL OUTCOMES IN A LARGE SINGLE-INSTITUTION CYSTECTOMY SERIES (2012) (1)
- ‘Should I get a PSA test?’ – the question is not that simple (2015) (1)
- Intraoperative consultation for the kidney. (1985) (1)
- Impact of a second transurethral resection on the staging of T1 bladder cancer: Editorial comment (2002) (1)
- Abstract 29: LONG-TERM FOLLOW UP OF INTERPOSITIONAL NERVE GRAFTING OF THE PROSTATIC PLEXUS AFTER OPEN PROSTATECTOMY (2013) (1)
- Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. (2005) (1)
- Functional Characterization of the Bladder Cancer Marker, BLCA-4 (2005) (1)
- Anesthesia requirements during transurethral needle ablation procedure. (1998) (1)
- 1668: Understanding Bladder Cancer Death: Will Pulling the Trigger for Cystectomy Sooner Save Lives? (2007) (1)
- Screen detected, low volume prostate cancer: the case for active treatment. (2008) (1)
- Locally advanced cancer of the prostate: diagnosis and management (1994) (1)
- COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer. (2005) (1)
- 1766 LENGTH OF STAY FOLLOWING RADICAL CYSTECTOMY: HOW LONG IS LONG ENOUGH? (2013) (1)
- MP5-20 NOTABLE OUTCOMES AND TRACKABLE EVENTS AFTER SURGERY (NOTES): A COMPOSITE MEASURE TO ASSESS UNCOMPLICATED RECOVERY AFTER RADICAL PROSTATECTOMY (2015) (1)
- MP60-13 PSOAS MUSCLE MASS AS A PREDICTOR OF SURVIVAL IN PATIENTS WHO UNDERGO RADICAL CYSTECTOMY (2014) (1)
- Comparing current care to the NCCN prostate cancer practice guidelines (1999) (1)
- Systemic absorption and pharmacokinetics of single-dose intravesical gemcitabine after transurethral resection of the bladder in non-muscle-invasive bladder cancer (2010) (1)
- Testicular cancer: diagnosis and staging. (1984) (1)
- Clinical Management of Renal Cell Cancer (1990) (1)
- PD42-07 IMPLEMENTATION OF METHODOLOGY TO CAPTURE DATA FROM PROSTATE MRI WITHIN A REGIONAL QUALITY-IMPROVEMENT COLLABORATIVE (2016) (1)
- Adult urologyEditorial comment (2002) (1)
- CURRENT INDICATIONS AND NEW POSSIBILITIES FOR ORGAN PRESERVATION IN CARCINOMA OF THE BLADDER (2000) (1)
- MP18-10 MI TREXIT: PILOT EVALUATION OF A STATE-WIDE INITIATIVE FOR IN-OFFICE TRANSPERINEAL VERSUS TRANSRECTAL PROSTATE BIOPSY UNDER LOCAL ANESTHESIA (2019) (1)
- Video analysis of skill and technique (VAST): Machine learning to assess the technical skill of surgeons performing robotic prostatectomy (2017) (1)
- [Prognosis prediction in patients with transitional cell carcinoma of the urinary bladder]. (1996) (0)
- VIRTUAL CYSTOSCOPY: AN INTRODUCTION, EARLY EXPERIENCE, AND CORRELATION WITH CONVENTIONAL CYSTOSCOPY (1999) (0)
- REAL-TIME HEALTH-RELATED QUALITY OF LIFE ASSESSMENT AMONG PROSTATE CANCER SURVIVORS (2009) (0)
- 675: Early Urinary Retention After Catheter Removal Following Radical Prostatectomy is Associated with Future Urethral Stricture Formation (2006) (0)
- Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a Phase II Hoosier Oncology Group Study. (2005) (0)
- PD12-09 THE INCIDENCE OF ACTIVE SURVEILLANCE FOR PRIMARY MANAGEMENT OF LOW-RISK PROSTATE CANCER IN A STATE-WIDE QUALITY IMPROVEMENT COLLABORATIVE (2014) (0)
- ILEAL RESERVOIR FOR BLADDER REPLACEMENT. AUTHOR'S REPLY (1997) (0)
- Finding the Nearest TRexit: Novel Transperineal Prostate Biopsy Approaches for All Practices (2020) (0)
- COORDINATE EXPRESSION OF CYTOKERATINS 7 AND 20 IN DISTINGUISHING BLADDER TRANSITIONAL CELL CARCINOMA FROM PROSTATE ADENOCARCINOMA (1999) (0)
- LIMITATIONS OF ABDOMINAL IMAGING FOR DETECTION OF LYMPH NODE METASTASES PRIOR TO PROSTATECTOMY: MP18‐06 (2017) (0)
- MP78-10 CONTEMPORARY USE OF ADJUVANT AND SALVAGE RADIOTHERAPY FOLLOWING RADICAL PROSTATECTOMY IN THE STATE OF MICHIGAN (2015) (0)
- MP23-18 ASSESSING THE IMPACT OF DECISION AID USE ON POST PROSTATECTOMY PATIENT REPORTED OUTCOMES (2021) (0)
- THE QUALITY OF ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER (2009) (0)
- Prevalence of the HOXB 13 G 84 E prostate cancer risk allele in men treated with radical prostatectomy (2014) (0)
- COMPARISON OF BODY IMAGE BETWEEN ILEAL CONDUIT AND ORTHOTOPIC NEOBLADDER PATIENTS AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER (2009) (0)
- MP12-11 RATES AND RISK FACTORS OF LOST TO FOLLOW UP IN PROSTATE CANCER PATIENTS MANAGED WITH ACTIVE SURVEILLANCE (2018) (0)
- Oncology : Prostate / Testis / Penis / Urethra A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer (2017) (0)
- Defining Quality Metrics for Active Surveillance: The MUSIC Experience. (2020) (0)
- 61 UNDERSTANDING AND IMPROVING UTILIZATION OF IMMEDIATE INTRAVESICAL CHEMOTHERAPY FOR PATIENTS WITH BLADDER CANCER (2012) (0)
- Controversies in T1 bladder Ca: Early cystectomy vs. TUR (2003) (0)
- MP42-01 MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE: PATTERNS OF CARE IN THE RADIOGRAPHIC STAGING OF MEN WITH NEWLY DIAGNOSED PROSTATE CANCER (2014) (0)
- Comprehensive Comparison of Heal th-Related Qual i ty of Li fe Af ter Contemporary Therapies for Local ized Prostate Cancer (2001) (0)
- 379: Racial Disparities in Radical Cystectomy Resource Utilization (2004) (0)
- 2215 TRANSPERINEAL MAPPING TEMPLATE PROSTATE BIOPSY AFTER PREVIOUS TRANSRECTAL ULTRASOUND PROSTATE BIOPSY DETECTS WORSE DISEASE BURDEN (2013) (0)
- MP66-15 MEASURING THE IMPACT OF A PHYSICIAN-LED COLLABORATIVE ON THE QUALITY OF PROSTATE CANCER CARE: 7 YEARS OF MAKING MUSIC (2020) (0)
- MP10-10 PATIENT-LEVEL VALIDATION OF PROSTATE CANCER DATA COLLECTED VIA AUTOMATED EXTRACTION FROM STRUCTURED AND UNSTRUCTURED ELECTRONIC HEALTH RECORD (EHR) RECORDS (2019) (0)
- The Forman/Velasco Article Reviewed (1998) (0)
- MP62-03 CONFIRMATORY TESTING OUTCOMES IN ACTIVE SURVEILLANCE: RESULTS FROM THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE (MUSIC) (2021) (0)
- 38 REGIONAL COLLABORATION TO IMPROVE STAGING PRACTICES AMONG MEN WITH PROSTATE CANCER (2011) (0)
- Clinical and Pathologic Staging of Renal Cell Carcinoma (2008) (0)
- 2008 Best of the Rest in Urological Survey2008 Best of the Rest in Urological Survey (2008) (0)
- PD38-13 REPEAT BIOPSY RATES FOR PREMALIGNANT LESIONS IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE (2015) (0)
- Principles of continent reconstruction (2012) (0)
- 1645 SHOULD PERINEURAL INVASION IN RADICAL PROSTATECTOMY SPECIMENS INFLUENCE SURVEILLANCE AMONG PROSTATE CANCER SURVIVORS? LONGITUDINAL EXPERIENCE IN 3,226 PATIENTS (2011) (0)
- Technique of radical cystectomy. (1983) (0)
- Assessing quality of care for prostate cancer (2005) (0)
- Editorial Comment. (2018) (0)
- Sexual Health Concerns Among Cancer Survivors: Testing a Novel Information-Need Measure Among Breast and Prostate Cancer Patients (2015) (0)
- Editorial Comment: Concurrent Cisplatin and Radiotherapy for Patients with Muscle Invasive Bladder Cancer Who Are Not Candidates for Radical Cystectomy (1996) (0)
- PD38-06 UNDERSTANDING THE USE OF PROSTATE BIOPSY AMONG MEN WITH LIMITED LIFE EXPECTANCY (2015) (0)
- Orthotopic bladder replacement in women (2004) (0)
- PD43-12 PROMIS INTEREST IN SEXUAL ACTIVITY AND SATISFACTION WITH SEX LIFE MEASURES IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY (2019) (0)
- DO PATIENTS WHO UNDERGO MULTIPARAMETRIC MRI FOR PROSTATE CANCER NEED ANY OTHER IMAGING? RESULTS FROM A STATEWIDE COLLABORATIVE: PD11‐11 (2017) (0)
- Current therapy for invasive bladder cancer. (1996) (0)
- Changing concepts in testis cancer 1 the management of (2013) (0)
- Complications in radical cystectomy and their prevention (1995) (0)
- Editorial comment. (2009) (0)
- Combined-Modality Therapy With Gemcitabine and Radiotherapy as a Bladder Preservation Strategy: Results of a Phase I Trial (2005) (0)
- 99: Prevalence of and Risk Factors for Prostatitis in African American Men: The Flint Men's Health Study (2006) (0)
- MP65-08 THE ROLE OF TRANSURETHRAL RESECTION OF BLADDER TUMOR AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER (2014) (0)
- 1420 RETROGRADE URETEROSCOPY IN PATIENTS WITH ORTHOTOPIC ILEAL NEOBLADDER RECONSTRUCTION FOR BLADDER CANCER: A 17-YEAR EXPERIENCE (2013) (0)
- Detection of Methylated Apoptosis-Associated Genes in Urine Sediments of Bladder Cancer Patients (2005) (0)
- 56 PRACTICE-BASED COLLABORATION TO IMPROVE THE USE OF IMMEDIATE INTRAVESICAL CHEMOTHERAPY (IVC) FOR NON-MUSCLE-INVASIVE BLADDER CANCER (2013) (0)
- 1597: Local Therapies for Low-Risk Prostate Cancer: Exploring the Potential Burden of Overtreatment (2006) (0)
- PD51-11 INSTITUTION OF A SMALL RENAL MASS QUALITY IMPROVEMENT INITIATIVE IN A STATEWIDE COLLABORATIVE (2018) (0)
- Conference on Prognostic Factors and Staging in Cancer Management: Contributions of Artificial Neural Networks and Other Statistical Methods (2001) (0)
- 310: Early Stage Bladder Cancer Surveillance Does Not Improve Survival if Patients Progress to Clinical T2 Disease (2004) (0)
- Utilization of a Virtual Tumor Board for the Care of Patients With Renal Masses: Experience From a Quality Improvement Collaborative. (2023) (0)
- MP5-19 THE IMPACT OF CARE COORDINATION ON RADICAL PROSTATECTOMY OUTCOMES (2015) (0)
- 383 ACCEPTANCE OF A PRE-OPERATIVE EDUCATIONAL SEMINAR ABOUT RECOVERY AFTER PROSTATE CANCER SURGERY (2012) (0)
- Therapeutic Radiation in Patients With a Rising Post-Prostatectomy PSA Level (1998) (0)
- Health PolicyEditorial Commentary (2015) (0)
- Current issues in bladder cancer (1992) (0)
- Cause-specific survival is high following radiotherapy or surgery for Gleason score 8–10 prostate cancer (2004) (0)
- UROLOGICAL ONCOLOGY: PROSTATE CANCER Autoantibody Signatures in Prostate Cancer (2006) (0)
- Re: a new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. (2011) (0)
- ROUTINE HOME HEALTH AFTER PROSTATECTOMY DOES NOT REDUCE ED VISITS OR CATHETER COMPLICATIONS: PD14‐04 (2017) (0)
- 1501 ESTABLISHING A THRESHOLD FOR PSA DOUBLING TIME IN PREDICTING OUTCOMES FOLLOWING SALVAGE RADIATION THERAPY (2013) (0)
- Open surgical partial nephrectomy for upper tract urothelial carcinoma (2014) (0)
- Prediction of Progression in pTa and pT1 Bladder Carcinomas With p53, p16 and pRb (2005) (0)
- MP20-03 PATIENT EXPERIENCE FOR TRANSPERINEAL BIOPSY UNDER LOCAL ANESTHESIA VERSUS TRANSRECTAL BIOPSY: RESULTS FROM THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE (2020) (0)
- Counseling the Patient on Choice of Therapy and Outcomes (2000) (0)
- 1547: Health-Seeking Behavior and Lower Urinary Tract Symptoms among a Cohort of African-American Men: The Flint Men's Healthstudy (2004) (0)
- Nested variant of urothelial carcinoma: A clinicopathologic and immunohistochemical study of 12 cases - Commentary (2006) (0)
- 1703 A COMPARISON OF PERIOPERATIVE COMPLICATIONS IN BLADDER CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY OR RADICAL CYSTECTOMY, ALONE (2010) (0)
- MP60-07 DETERMINING THE IMPACT OF GENOMIC CLASSIFIER TESTING ON PATIENT-REPORTED QUALITY OF LIFE IN MEN AT HIGH-RISK OF POST-PROSTATECTOMY RECURRENCE: RESULTS FROM THE G-MINOR TRIAL (2021) (0)
- Delayed radical prostatectomy after a period of active surveillance is not associated with the use of secondary treatments compared with immediate prostatectomy (2021) (0)
- Unsuspected Adenocarcinoma of Theprostate in a Series of Cystoprostatectomies for Bladder Cancer (1987) (0)
- THE IMPACT OF BLADDER NECK SPARING AND NERVE SPARING ON URINARY FUNCTION AND CANCER CONTROL ASSOCIATED WITH RADICAL PROSTATECTOMY (1999) (0)
- PD56-08 MOLECULAR CLASSIFIER TESTING FOR NEWLY DIAGNOSED LOCALIZED PROSTATE CANCER IN THE STATE OF MICHIGAN (2018) (0)
- A Generalized Assessment of the Impact of Regionalization and Provider Learning on Patient Outcomes (2016) (0)
- Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma: Commentary (2006) (0)
- Immunologic characteristics of a murine renal adenocarcinoma. Abstr. (1981) (0)
- 7. Current therapy for invasive bladder cancer (0)
- PD54-01 REDEFINING OPIOID USE AFTER PROSTATECTOMY: RESULTS FROM THE IMPLEMENTATION OF A STATEWIDE OPIOID-FREE PAIN OPTIMIZATION PATHWAY (2022) (0)
- MP83-09 EVALUATING THE INDICATIONS AND SAFETY OF PROSTATE BIOPSIES PERFORMED IN ELDERLY PATIENTS: A REVIEW OF A STATEWIDE COLLABORATIVE (2020) (0)
- Reply to K.P. Weinfurt et al. (2020) (0)
- 554: Prospective Comparison of Short-Term Recovery between Open and Robotic Radical Prostatectomy (2007) (0)
- The added influence of genomics and post‐MRI confirmatory biopsy results to MRI results alone on medical decision making for men with favorable risk prostate cancer being considered for active surveillance (2022) (0)
- Adjuvant chemotherapy for bladder cancer: Introduction (1990) (0)
- MP69-19 VARIATION IN THE FREQUENCY OF PREMALIGNANT LESIONS AMONG PATIENTS UNDERGOING PROSTATE BIOPSY IN MICHIGAN (2014) (0)
- MP22-03 UTILIZATION OF SALVAGE RADIATION THERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2018) (0)
- MP44-09 OVERTREATMENT AND UNDERUTILIZATION OF WATCHFUL WAITING IN MEN WITH LIMITED LIFE EXPECTANCY: AN ANALYSIS OF THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE REGISTRY (2019) (0)
- 26 Renal Cell Carcinoma (1995) (0)
- Editorial Comment. (2016) (0)
- PD47-06 PATHOLOGICAL UPGRADING FROM GLEASON 3+3 DISEASE AFTER RADICAL PROSTATECTOMY: THE IMPLICATIONS FOR CONFIRMATORY TESTING (2018) (0)
- PD44-11 UNDERSTANDING THE PERFORMANCE OF ACTIVE SURVEILLANCE SELECTION CRITERIA IN REAL-WORLD PRACTICE (2015) (0)
- DISCRIMINATION OF CARE TO PATIENT DIFFERENCES: A USEFUL TOOL FOR EVALUATING QUALITY? (2008) (0)
- USE OF BASELINE, PRE-OPERATIVE, CLINICALLY ACCESSIBLE PARAMETERS TO PREDICT THERAPEUTIC EFFICACY OF RADICAL PROSTATECTOMY (1999) (0)
- Urinary diversion (1992) (0)
- Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. (2011) (0)
- Delayed urologic cancer care in the COVID‐19 pandemic: Patients' experiences (2022) (0)
- 125 THE DISSEMINATION OF INTENSITY-MODULATED RADIOTHERAPY AND ROBOTIC PROSTATECTOMY AMONG MEN AT LOW RISK OF DYING FROM PROSTATE CANCER (2013) (0)
- PD25-08 UNDERSTANDING THE RELATIONSHIP BETWEEN EPISODE COSTS AND DEVIATIONS FROM AN UNCOMPLICATED RADICAL PROSTATECTOMY RECOVERY PATHWAY (2016) (0)
- 443: Sexual Behavior, Sexually Transmitted Diseases, and the Risk of Prostate Cancer in African American Men: The Flint Men’s Health Study (2004) (0)
- Re: gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial. (2011) (0)
- Proceedings of the international conference on androgenic hormones, prostate cancer, and benign prostatic hyperplasia (1996) (0)
- Long-Term Effects of Bacille Calmette-Guérin Perfusion Therapy for Treatment of Transitional Cell Carcinoma In Situ of Upper Urinary Tract (2005) (0)
- Neoadjuvant docetaxel and capecitabine in patients (Pts) with high-risk prostate cancer (PCa): Final results of a phase II trial (2007) (0)
- Functional intrapelvic neuroanatomy of the male urethral sphincter assessed by intraoperative nerve stimulation (2002) (0)
- 177: Incremental Risk of Mortality Associated with Multiple Complications Following Bladder Cancer Surgery (2005) (0)
- 676: Obesity Affects Health Related Quality of Life at Baseline Before and in Recovery after Radical Retropubic Prostatectomy (2005) (0)
- 1818 COMPARATIVE EFFECTIVENESS OF EXTERNAL BEAM RADIATION APPROACHES FOR PROSTATE CANCER (2012) (0)
- MP54-12 PROSPECTIVE RANDOMIZED TRIAL OF GENE EXRESSION CLASSIFIER UTILTY IN MEN AT HIGH RISK OF RECURRENCE FOLLOWING RADICAL PROSTATECTOMY (2019) (0)
- MP20-15 PROSPECTIVE EVALUATION OF A NOVEL TRANSPERINEAL ELECTROMAGNETICALLY-TRACKED MR/US FUSION BIOPSY SYSTEM (2019) (0)
- ETS rearrangements and prostate cancer initiation Reply (2008) (0)
- MP42-08 INSTITUTION OF A WEB-BASED PATIENT-REPORTED OUTCOMES (PRO) SYSTEM FOR RADICAL PROSTATECTOMY IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE (2015) (0)
- Gastrointestinal and Urinary Events: Key Deviation Drivers from an Uncomplicated Radical Prostatectomy Recovery Pathway (2015) (0)
- PD19-06 VIDEO-BASED PEER REVIEW OF ROBOT-ASSISTED RADICAL PROSTATECTOMY IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE (2015) (0)
- MP54-11 PELVIC LYMPH NODE DISSECTION DURING ROBOTIC PROSTATECTOMY IN THE MUSIC COLLABORATIVE (2019) (0)
- Re: effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. (2011) (0)
- UROLOGY FOUNDED IN 1917 BY HUGH HAMPTON YOUNG (1989) (0)
- Significance of the Time Period Between Diagnosis of Muscle Invasion and Radical Cystectomy With Regard to the Prognosis of Transitional Cell Carcinoma of the Urothelium in the Bladder (2005) (0)
- 052 Construct Validity of the Patient Reported Outcome Measurement Information System (PROMIS) Sexual Function and Satisfaction measures (SexFs) in prostate cancer patients following Radical Prostatectomy (2019) (0)
- 1376: Why Bladder Cancer Surveillance May not be Effective for High Risk Patients Allowed to Progress to Muscle Invasion (2005) (0)
- PD12-02 UTILIZATION AND OUTCOMES OF REPEAT PROSTATE BIOPSY IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE (2015) (0)
- PD13-02 TRENDS IN PROSTATE CANCER TREATMENT: DATA FROM THE MICHIGAN UROLOGIC SURGICAL IMPROVEMENT COLLABORATIVE (2020) (0)
- Editorial Comment. (2016) (0)
- 1345 UNDERSTANDING THE IMPACT OF THE DOMINANT NODULE AND SIZE OF THE PROSTATE ON BIOCHEMICAL RECURRENCE IN MEN WITH PROSTATE CANCER (2013) (0)
- Quality assurance in urologic oncology: a radical prostatectomy experience of 2254 cases (2005) (0)
- 1029: Racial Differences in Serum Prostate Specific Antigen (PSA) Doubling Time, Histopathological Variables and Long-Term PSA Recurrence Between African American and Willte American Men Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer (2004) (0)
- LONG TERM FOLLOW-UP OF RENAL FUNCTION AND UPPER TRACT STATUS AFTER ILEAL CONDUIT DIVERSION (1999) (0)
- PD26-02 USING A PREBIOPSY CHECKLIST TO UNDERSTAND RISK FACTORS ASSOCIATED WITH INFECTION-RELATED HOSPITALIZATION FOLLOWING PROSTATE BIOPSY (2016) (0)
- MP6-03 TOWARD BETTER RADIOGRAPHIC STAGING OF MEN WITH EARLY-STAGE PROSTATE CANCER (2014) (0)
- Impact of early prostate cancer diagnosis in the United States. (2011) (0)
- PD46-01 FACTORS THAT INFLUENCE DECISION AID USE IN PROSTATE CANCER (2021) (0)
- Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy: Commentary (2006) (0)
- 483 Video-based independent peer review of robot-assisted radical prostatectomy in a statewide quality improvement collaborative (2015) (0)
- Editorial Comment: Long-Term Followup of a Bladder Carcinoma Cohort (1997) (0)
- Editorial Comment: Black Race is an Adverse Prognostic Factor for Prostate Cancer Recurrence Following Radical Prostatectomy in an Equal Access Health Care Setting (1996) (0)
- 674: Apical Dissection Technique During Radical Retropubic Prostatectomy Influences Rate and Absolute Development of Postoperative Urinary Continence (2006) (0)
- Regular vs. selective use of closed suction drains following robot-assisted radical prostatectomy: results from a regional quality improvement collaborative (2019) (0)
- Can frequency of prostate biopsy on active surveillance be reduced without significantly increasing risk (2017) (0)
- 133: Factors Associated with Increased Resource Utilization Following Radical Cystectomy (2004) (0)
- MP12-12 EVALUATING PRACTICE PATTERNS REGARDING PROSTATE BIOPSIES PERFORMED IN ELDERLY PATIENTS (2020) (0)
- 211: Risk Factors for Prolonged Length of Stay Following Urologic Surgery: The National Surgical Quality Improvement Program (2006) (0)
- 1489 COUPLES' EXPECTATIONS OF ERECTILE RECOVERY AFTER RADICAL PROSTATECTOMY FOCUS ON SELF- AND SURGEON EFFICACY, NOT ON NERVE DAMAGE (2013) (0)
- Editorial: Urinary diversion (2004) (0)
- Re: External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. (1985) (0)
- 557: Adoption of New Technology and Health Care Quality: Surgical Margins Following Robotic Prostatectomy (2007) (0)
- USE OF PELVIC FLOOR REHABILITATION IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE: PATIENT AND COST CHARACTERISTICS: MP69‐03 (2017) (0)
- REPEAT PROSTATE BIOPSY PRACTICE PATTERNS IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE: PD43‐10 (2017) (0)
- Selecting and Counseling Patients for Cystectomy or Cystoprostatectomy (2001) (0)
- Screening, Diagnosis, and Staging of Renal Cell Carcinoma (2000) (0)
- Prospective randomized trial of gene expression classifier utility in men at high risk of recurrence following radical prostatectomy (G-MINOR) (2019) (0)
- CAN FREQUENCY OF PROSTATE BIOPSY ON ACTIVE SURVEILLANCE BE REDUCED WITHOUT SIGNIFICANTLY INCREASING RISK?: MP43‐01 (2017) (0)
- INS PstIPolymorphism and Prostate Cancer in African-American Men (2005) (0)
- Re: Hexylaminolaevulinate Fluorescence Cystoscopy in Patients Previously Treated With Intravesical Bacille Calmette-Guérin (2011) (0)
- Business of UrologyEditorial Commentary (2016) (0)
- 608 Needle disinfectant technique during prostate biopsy is associated with less infection-related hospitalization: Results from a surgical collaborative (2016) (0)
- PROSPECTIVE MONITORING OF IMAGING GUIDELINE ADHERENCE IN A STATEWIDE SURGICAL COLLABORATIVE: USE OF STATISTICAL PROCESS METHODS: MP92‐12 (2017) (0)
- Assessment of urinary HRQOL in post-prostatectomy patients using epic A patient-reported validated instrument (2001) (0)
- Convalescence And Recovery Evaluation (2016) (0)
- PROSTATE CANCER STAGING: EVALUATION OF NOMOGRAM PREDICTING UNFAVORABLE PATHOLOGY (1999) (0)
- PD25-10 A STATEWIDE INTERVENTION TO REDUCE THE USE OF LOW VALUE IMAGING AMONG MEN WITH NEWLY-DIAGNOSED PROSTATE CANCER. (2016) (0)
- Correction: Implementation of prostate cancer treatment decision aid in Michigan: a qualitative study (2023) (0)
- Legends in urology. (2014) (0)
- MP62-14 THE INFLUENCE OF MAGNETIC RESONANCE IMAGING, GENOMIC CLASSIFIERS, AND POST-MAGNETIC RESONANCE IMAGING BIOPSY RESULTS ON SHARED-DECISION MAKING IN NEWLY DIAGNOSED FAVORABLE RISK PROSTATE CANCER PATIENTS (2021) (0)
- Editorial comment. (2009) (0)
- Cancer screening. (2020) (0)
- PD58-08 A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE’S ADHERENCE TO 2017 AUA GUIDELINES REGARDING INITIAL EVALUATION OF RENAL MASSES (2019) (0)
- 2006 Best of the Rest in Urological Survey (2006) (0)
- MP17-02 THE IMPACT OF CONFIRMATORY TESTING ON THE ADOPTION OF ACTIVE SURVEILLANCE FOR MEN WITH FAVORABLE-RISK PROSTATE CANCER (2018) (0)
- PD54-11 IMPLEMENTATION OF A STATE-WIDE QUALITY ASSURANCE INITIATIVE FOR PROSTATE MRI AND FUSION BIOPSY (2020) (0)
- 178: National Trends in the Utilization and Outcomes of Cystectomy (2005) (0)
- 1166: Urologic Oncology Training May Improve Early Experience with Robot-Assisted Radical Prostatectomy (2006) (0)
- 1405 RESULTS FROM A RANDOMIZED CONTROLLED STUDY OF PROSTATE CAPSULE SPARING (PCS) VERSUS NERVE SPARING (NS) CYSTECTOMY AND ORTHOTOPIC NEOBLADDER FOR UROTHELIAL CANCER (2012) (0)
- Defining the indications for pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients within a statewide quality improvement collaborative (2019) (0)
- 176: Preoperative Risk Factors Associated with 30-Day Morbdity Following Urologic Surgery: The National Surgical Quality Improvement Program (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With James E. Montie?
James E. Montie is affiliated with the following schools:
